The EHLTF is run on a voluntary basis by an elected group of seven individuals from the National Associations and to sustain the Federation a modest fee is charged to each of them. However, to fully achieve the aims and objectives of the Federation additional funding is needed.
We rely on the generous contributions made by the pharmaceutical companies Novartis, Astellas and Roche, that are closely associated with transplantation. Without their continued financial support the ability of the Federation to reach out and touch the lives of the many heart and lung transplant recipients and their families within the European community would be impossible.
The EHLTF is a purely voluntary organisation and all members of the EHLTF Executive Committee act in an unpaid voluntary capacity.
As with all organisations, certain operational expenditure has to be met to cover such areas as Insurance, website costs, postage and printing, telephone and internet costs, office equipment and stationary costs, meeting room rentals and refreshments, travelling and hotel costs attending and organising our Annual General Assembly.
The best way is to contact the Chairman or one of the the members of our Executive Committee.
You can find contact details at our website Contact us
European Heart and Lung Transplant Federation (EHLTF) (a.i.s.b.l)
route de Lennik 808, 1070 Bruxelles, Belgique
© EHLTF 2022 All Rights Reserved